PBA

Paradigm Biocapital Advisors Portfolio holdings

AUM $2.34B
This Quarter Return
+0.22%
1 Year Return
+13.3%
3 Year Return
+245.82%
5 Year Return
–
10 Year Return
–
AUM
$2.87B
AUM Growth
+$2.87B
Cap. Flow
+$202M
Cap. Flow %
7.01%
Top 10 Hldgs %
73.56%
Holding
35
New
4
Increased
20
Reduced
3
Closed
7

Top Buys

1
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$76.8M
2
PCVX icon
Vaxcyte
PCVX
$65.1M
3
JANX icon
Janux Therapeutics
JANX
$59.7M
4
RVMD icon
Revolution Medicines
RVMD
$54.2M
5
MLTX icon
MoonLake Immunotherapeutics
MLTX
$45.5M

Top Sells

1
KURA icon
Kura Oncology
KURA
$84.6M
2
ARVN icon
Arvinas
ARVN
$57.6M
3
IMVT icon
Immunovant
IMVT
$38.9M
4
CGEM icon
Cullinan Oncology
CGEM
$38.9M
5
MRUS icon
Merus
MRUS
$32.2M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SRRK icon
26
Scholar Rock
SRRK
$3.3B
$17.3M 0.6%
+400,000
New +$17.3M
ORKA
27
Oruka Therapeutics, Inc. Common Stock
ORKA
$578M
$15.9M 0.55%
819,660
+100,000
+14% +$1.94M
AGIO icon
28
Agios Pharmaceuticals
AGIO
$2.36B
$9.08M 0.32%
+276,439
New +$9.08M
ARVN icon
29
Arvinas
ARVN
$580M
– –
-2,339,961
Closed -$57.6M
CATX icon
30
Perspective Therapeutics
CATX
$251M
– –
-919,692
Closed -$12.3M
CGEM icon
31
Cullinan Oncology
CGEM
$456M
– –
-2,321,013
Closed -$38.9M
CMPS
32
Compass Pathways
CMPS
$452M
– –
-1,160,000
Closed -$7.31M
IMVT icon
33
Immunovant
IMVT
$2.91B
– –
-1,362,827
Closed -$38.9M
KROS icon
34
Keros Therapeutics
KROS
$638M
– –
-525,037
Closed -$30.5M
KURA icon
35
Kura Oncology
KURA
$732M
– –
-4,331,321
Closed -$84.6M
1
2